Events
Ansu Satpathy, Stanford. “High-Throughput Genomics in Cancer Immunotherapy”
Talk description to come.
Register for the Livestream
About the Speaker
Dr. Ansuman Satpathy, M.D., Ph.D., is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the director of the Stanford Center for Immunotherapy Design, co-director of the Parker Institute for Cancer Immunotherapy, and co-director of the Immunotherapy Program in the Stanford Cancer Institute.
Ansu’s research combines expertise in immunology, high-throughput genomics, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics. High-throughput genomics is important in biomedical research to rapidly analyze large amounts of genetic material that provide insights into the structure, function and variations of genomes. Ansu uses transcriptomics and epigenomics to understand how immune cells behave in the tumor microenvironment and during immune response, how cells can be tweaked to induce cell states associated with productive immunity, or to reverse dysfunctional cell states associated with therapy resistance.
He is a co-founder of Immunai, Cartography Biosciences, Santa Ana Biosciences, and Prox Biosciences, and a venture partner at Wing Venture Capital.
Ansu holds a BS in molecular biology and BA in philosophy from the University of Illinois, an MD and PhD in immunology from Washington University in St.Louis, and completed his clinical residency and postdoctoral training in genetics at Stanford University.
